iBio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.75
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.12
|
-1.96
|
0.16
|
7.55%
|
|
2022-06-30
|
-2.12
|
-1.96
|
0.16
|
7.55%
|
|
2022-03-31
|
-1.37
|
-1.50
|
-0.13
|
-9.49%
|
|
2021-12-31
|
-1.00
|
-1.25
|
-0.25
|
-25.00%
|
|
2021-09-30
|
-1.25
|
-1.00
|
0.25
|
20.00%
|
|
2021-06-30
|
-0.04
|
0.01
|
0.05
|
125.00%
|
|
2021-03-31
|
-1.25
|
-1.00
|
0.25
|
20.00%
|
|
2020-12-31
|
-1.00
|
-1.00
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.96
|
|
2022-06-30
|
-5.71
|
|
2021-06-30
|
-4.20
|
|
2019-06-30
|
-0.94
|
|
2018-06-30
|
-1.56
|
|
2017-06-30
|
-1.64
|
|
2016-06-30
|
-29.96
|
|
2015-06-30
|
-21.92
|
|
2014-06-30
|
-29.01
|
|
2012-06-30
|
-21.56
|
|
2011-06-30
|
-3.70
|
|
2010-06-30
|
-30.11
|
|
2009-06-30
|
-27.79
|